2025-04-012026-03-312026-03-31false10583051TICKHILL DENTAL & IMPLANT CENTRE LIMITED2026-10-01falseiso4217:GBPxbrli:pure105830512025-03-31105830512026-03-31105830512025-04-012026-03-31105830512024-03-31105830512025-03-31105830512024-04-012025-03-3110583051bus:SmallEntities2025-04-012026-03-3110583051bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3110583051bus:FullAccounts2025-04-012026-03-3110583051bus:PrivateLimitedCompanyLtd2025-04-012026-03-3110583051core:WithinOneYear2026-03-3110583051core:AfterOneYear2026-03-3110583051core:WithinOneYear2025-03-3110583051core:AfterOneYear2025-03-3110583051core:ShareCapital2026-03-3110583051core:SharePremium2026-03-3110583051core:RevaluationReserve2026-03-3110583051core:OtherReservesSubtotal2026-03-3110583051core:RetainedEarningsAccumulatedLosses2026-03-3110583051core:ShareCapital2025-03-3110583051core:SharePremium2025-03-3110583051core:RevaluationReserve2025-03-3110583051core:OtherReservesSubtotal2025-03-3110583051core:RetainedEarningsAccumulatedLosses2025-03-3110583051core:LandBuildings2026-03-3110583051core:PlantMachinery2026-03-3110583051core:Vehicles2026-03-3110583051core:FurnitureFittings2026-03-3110583051core:OfficeEquipment2026-03-3110583051core:NetGoodwill2026-03-3110583051core:IntangibleAssetsOtherThanGoodwill2026-03-3110583051core:ListedExchangeTraded2026-03-3110583051core:UnlistedNon-exchangeTraded2026-03-3110583051core:LandBuildings2025-03-3110583051core:PlantMachinery2025-03-3110583051core:Vehicles2025-03-3110583051core:FurnitureFittings2025-03-3110583051core:OfficeEquipment2025-03-3110583051core:NetGoodwill2025-03-3110583051core:IntangibleAssetsOtherThanGoodwill2025-03-3110583051core:ListedExchangeTraded2025-03-3110583051core:UnlistedNon-exchangeTraded2025-03-3110583051core:LandBuildings2025-04-012026-03-3110583051core:PlantMachinery2025-04-012026-03-3110583051core:Vehicles2025-04-012026-03-3110583051core:FurnitureFittings2025-04-012026-03-3110583051core:OfficeEquipment2025-04-012026-03-3110583051core:NetGoodwill2025-04-012026-03-3110583051core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3110583051core:ListedExchangeTraded2025-04-012026-03-3110583051core:UnlistedNon-exchangeTraded2025-04-012026-03-3110583051core:MoreThanFiveYears2025-04-012026-03-3110583051core:Non-currentFinancialInstruments2026-03-3110583051core:Non-currentFinancialInstruments2025-03-3110583051dpl:CostSales2025-04-012026-03-3110583051dpl:DistributionCosts2025-04-012026-03-3110583051core:LandBuildings2025-04-012026-03-3110583051core:PlantMachinery2025-04-012026-03-3110583051core:Vehicles2025-04-012026-03-3110583051core:FurnitureFittings2025-04-012026-03-3110583051core:OfficeEquipment2025-04-012026-03-3110583051dpl:AdministrativeExpenses2025-04-012026-03-3110583051core:NetGoodwill2025-04-012026-03-3110583051core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3110583051dpl:GroupUndertakings2025-04-012026-03-3110583051dpl:ParticipatingInterests2025-04-012026-03-3110583051dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3110583051core:ListedExchangeTraded2025-04-012026-03-3110583051dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3110583051core:UnlistedNon-exchangeTraded2025-04-012026-03-3110583051dpl:CostSales2024-04-012025-03-3110583051dpl:DistributionCosts2024-04-012025-03-3110583051core:LandBuildings2024-04-012025-03-3110583051core:PlantMachinery2024-04-012025-03-3110583051core:Vehicles2024-04-012025-03-3110583051core:FurnitureFittings2024-04-012025-03-3110583051core:OfficeEquipment2024-04-012025-03-3110583051dpl:AdministrativeExpenses2024-04-012025-03-3110583051core:NetGoodwill2024-04-012025-03-3110583051core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110583051dpl:GroupUndertakings2024-04-012025-03-3110583051dpl:ParticipatingInterests2024-04-012025-03-3110583051dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110583051core:ListedExchangeTraded2024-04-012025-03-3110583051dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110583051core:UnlistedNon-exchangeTraded2024-04-012025-03-3110583051core:NetGoodwill2026-03-3110583051core:IntangibleAssetsOtherThanGoodwill2026-03-3110583051core:LandBuildings2026-03-3110583051core:PlantMachinery2026-03-3110583051core:Vehicles2026-03-3110583051core:FurnitureFittings2026-03-3110583051core:OfficeEquipment2026-03-3110583051core:AfterOneYear2026-03-3110583051core:WithinOneYear2026-03-3110583051core:ListedExchangeTraded2026-03-3110583051core:UnlistedNon-exchangeTraded2026-03-3110583051core:ShareCapital2026-03-3110583051core:SharePremium2026-03-3110583051core:RevaluationReserve2026-03-3110583051core:OtherReservesSubtotal2026-03-3110583051core:RetainedEarningsAccumulatedLosses2026-03-3110583051core:NetGoodwill2025-03-3110583051core:IntangibleAssetsOtherThanGoodwill2025-03-3110583051core:LandBuildings2025-03-3110583051core:PlantMachinery2025-03-3110583051core:Vehicles2025-03-3110583051core:FurnitureFittings2025-03-3110583051core:OfficeEquipment2025-03-3110583051core:AfterOneYear2025-03-3110583051core:WithinOneYear2025-03-3110583051core:ListedExchangeTraded2025-03-3110583051core:UnlistedNon-exchangeTraded2025-03-3110583051core:ShareCapital2025-03-3110583051core:SharePremium2025-03-3110583051core:RevaluationReserve2025-03-3110583051core:OtherReservesSubtotal2025-03-3110583051core:RetainedEarningsAccumulatedLosses2025-03-3110583051core:NetGoodwill2024-03-3110583051core:IntangibleAssetsOtherThanGoodwill2024-03-3110583051core:LandBuildings2024-03-3110583051core:PlantMachinery2024-03-3110583051core:Vehicles2024-03-3110583051core:FurnitureFittings2024-03-3110583051core:OfficeEquipment2024-03-3110583051core:AfterOneYear2024-03-3110583051core:WithinOneYear2024-03-3110583051core:ListedExchangeTraded2024-03-3110583051core:UnlistedNon-exchangeTraded2024-03-3110583051core:ShareCapital2024-03-3110583051core:SharePremium2024-03-3110583051core:RevaluationReserve2024-03-3110583051core:OtherReservesSubtotal2024-03-3110583051core:RetainedEarningsAccumulatedLosses2024-03-3110583051core:AfterOneYear2025-04-012026-03-3110583051core:WithinOneYear2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110583051core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3110583051core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3110583051core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3110583051core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3110583051core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3110583051core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3110583051core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3110583051core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110583051core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110583051bus:Director12025-04-012026-03-3110583051bus:Director22025-04-012026-03-3110583051core:FurnitureFittingsToolsEquipment2025-03-3110583051core:FurnitureFittingsToolsEquipment2025-04-012026-03-3110583051core:FurnitureFittingsToolsEquipment2026-03-31

TICKHILL DENTAL & IMPLANT CENTRE LIMITED

Registered Number
10583051
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

TICKHILL DENTAL & IMPLANT CENTRE LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

Mr A Patel
Mrs P Patel

Registered Address

50 Hallam Grange Crescent
Sheffield
S10 4BD

Place of Business

36 Sunderland Street

Tickhill

Doncaster

DN11 9QJ


Registered Number

10583051 (England and Wales)
TICKHILL DENTAL & IMPLANT CENTRE LIMITED
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Intangible assets370,00080,000
Tangible assets411,5386,993
81,53886,993
Current assets
Stocks515,7451,387
Debtors62,8736,802
Cash at bank and on hand28,71026,699
47,32834,888
Creditors amounts falling due within one year7(292,240)(239,855)
Net current assets (liabilities)(244,912)(204,967)
Total assets less current liabilities(163,374)(117,974)
Net assets(163,374)(117,974)
Capital and reserves
Called up share capital100100
Profit and loss account(163,474)(118,074)
Shareholders' funds(163,374)(117,974)
The financial statements were approved and authorised for issue by the Board of Directors on 1 October 2026, and are signed on its behalf by:
Mr A Patel
Director
Mrs P Patel
Director

Registered Company No. 10583051
TICKHILL DENTAL & IMPLANT CENTRE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 20026 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Interest income
Interest income is recognised using the effective interest rate method.
Operating leases
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made. Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows: Goodwill - 10% straight line
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Plant and machinery25-
Fixtures and fittings25-
Office Equipment-3
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20262025
Average number of employees during the year55
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 25250,000250,000
At 31 March 26250,000250,000
Amortisation and impairment
At 01 April 25170,000170,000
Charge for year10,00010,000
At 31 March 26180,000180,000
Net book value
At 31 March 2670,00070,000
At 31 March 2580,00080,000
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 257,69125,5029,43642,629
Additions7,904--7,904
At 31 March 2615,59525,5029,43650,533
Depreciation and impairment
At 01 April 253,25122,9499,43635,636
Charge for year2,721638-3,359
At 31 March 265,97223,5879,43638,995
Net book value
At 31 March 269,6231,915-11,538
At 31 March 254,4402,553-6,993
5.Stocks

2026

2025

££
Raw materials and consumables1,918387
Work in progress13,8271,000
Total15,7451,387
6.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables1,3961,559
Other debtors-3,450
Prepayments and accrued income1,4771,793
Total2,8736,802
7.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables12,7325,112
Taxation and social security105,54281,624
Other creditors173,713152,019
Accrued liabilities and deferred income2531,100
Total292,240239,855
8.Related party transactions
On 2 April 2026 APP Smile Tickhill Ltd acquired 100% of the issued share capital in Tickhill Dental & Implant Centre Limited.